Gerard M. Crotty
Tullamore, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
SKY92 Identifies High-Risk Newly Diagnosed Multiple Myeloma With Inferior Progression-Free Survival and Implicates NUF2 as a Candidate Driver.
Journal: European journal of haematology
Published: June 30, 2026
ATYPICAL BRAF MUTATIONS IN HAIRY CELL LEUKEMIA: DIAGNOSTIC AND THERAPEUTIC CONSIDERATIONS.
Journal: Experimental oncology
Published: July 11, 2025
Type I Cryoglobulinemic Vasculitis.
Journal: The New England journal of medicine
Published: June 21, 2023
Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high-risk features and reduced treatment-free-intervals.
Journal: European journal of haematology
Published: April 25, 2022
Epidemiology of chronic lymphocytic leukaemia in an Irish subpopulation with total case ascertainment: an additional tool for health economic planning.
Journal: British journal of haematology
Published: November 16, 2021
Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma.
Journal: American journal of hematology
Published: August 11, 2021
Myeloproliferative neoplasms with a low (<5%) CALR mutation allele burden.
Journal: Blood cells, molecules & diseases
Published: June 23, 2021
A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 29, 2020
Biclonal lymphoproliferative disorders: another association with NOTCH1-mutated chronic lymphocytic leukaemias.
Journal: Irish journal of medical science
Published: August 09, 2019
Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLL.
Journal: Leukemia & lymphoma
Published: September 20, 2017
NOTCH1 mutation in type II Hodgkin transformation of chronic lymphocytic leukemia.
Journal: Leukemia & lymphoma
Published: October 01, 2016
Transcultural care and individuals with an intellectual disability.
Journal: Journal of intellectual disabilities : JOID
Published: November 09, 2015
Last Updated: 09/26/2026